Your browser doesn't support javascript.
loading
Patient reported outcomes of intermittent self-dilatation after direct vision internal urethrotomy.
Scheipner, Lukas; Jankovic, Doroteja; Jasarevic, Samra; Seidl, Matthias; Altziebler, Julia V; Pemberger, Karl; Pohl, Klara C; Primus, Günter; Tian, Zhe; Leitsmann, Marianne; Ahyai, Sascha.
Afiliação
  • Scheipner L; Department of Urology, Medical University of Graz, Graz, Austria.
  • Jankovic D; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
  • Jasarevic S; Department of Urology, Medical University of Graz, Graz, Austria.
  • Seidl M; Department of Urology, Medical University of Graz, Graz, Austria.
  • Altziebler JV; Department of Urology, Medical University of Graz, Graz, Austria.
  • Pemberger K; Department of Urology, Medical University of Graz, Graz, Austria.
  • Pohl KC; Department of Urology, Medical University of Graz, Graz, Austria.
  • Primus G; Department of Urology, Medical University of Graz, Graz, Austria.
  • Tian Z; Department of Urology, Medical University of Graz, Graz, Austria.
  • Leitsmann M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
  • Ahyai S; Department of Urology, Medical University of Graz, Graz, Austria.
Neurourol Urodyn ; 43(3): 664-671, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38221870
ABSTRACT

PURPOSE:

Long-term results on quality of life (QoL) as well as clinical outcomes of intermittent self-dilatation (ISD) of the urethra after direct visual internal urethrotomy (DVIU) are scarce. The aim of this study was to prospectively evaluate patient reported outcomes (PROs) on voiding symptoms and QoL in a large cohort of urethral stricture patients performing ISD.

METHODS:

We identified a total of 121 patients who performed ISD following DVIU between 2008 and 2013. Baseline assessment was conducted for each patient before ISD was started. Follow-up visits were scheduled in 6-month intervals. Each assessment included the following questionnaires International prostate symptom score (IPSS), IPSS quality of life index (IPSS-QoL), patient global impression of severity (PGI-S), and patient global impression of improvement (PGI-I). Additional parameters were maximum urinary flow rate (Qmax ), postvoid residual urine, rate of complications, and stricture recurrence. Linear mixed models were used to examine the change over the course of the follow-up visits to the baseline.

RESULTS:

The median age of the patients was 58 years (interquartile range [IQR] 43-70). The median follow-up was 17 months (IQR 7-30). Mean change from baseline IPSS was -6.1, -5.9, -4.2, and -4.8 points at 6, 24, 36, and 48 months. Mean change from baseline IPSS-QoL was -1.3, -1.4, -1.6, and -1.8 points, respectively. Mean PGI-I was 1.7 points at 6, 1.9 points at 24, 1.9 points at 36, and 2.2 points at 48 months after ISD initiation. Mean change of Qmax ranged from 1.7 at 6 to 2.2 mL/s at 48 months. The median complication rate was 3.3% per 6-month ISD interval. Overall, 11 patients developed stricture recurrence (9%).

CONCLUSION:

ISD after DVIU had no negative impact on patients' QoL (IPSS-QoL, PGI-I, PGI-S). Urodynamic parameters remained stable for up to 48 months with low complications and an acceptable stricture recurrence rate.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Uretra Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Uretra Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Neurourol Urodyn Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Áustria